Caption Management, LLC Verona Pharma PLC Call Options Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$15.46 - $30.16 $1.55 Million - $3.02 Million	-100,000 Reduced 71.43%	40,000 $1.15 Million
Q2 2024 Aug 14, 2024	BUY	$11.48 - $17.02 $1.61 Million - $2.38 Million	140,000 New	140,000 $2.02 Million
Q1 2023 May 15, 2023	SELL	$18.06 - $25.27 $3.16 Million - $4.42 Million	-175,100 Reduced 89.75%	20,000 $401,000
Q4 2022 Feb 14, 2023	BUY	$9.84 - $26.13 $1.18 Million - $3.14 Million	120,100 Added 160.13%	195,100 $5.1 Million
Q3 2022 Nov 14, 2022	BUY	$4.14 - $13.59 $310,500 - $1.02 Million	75,000 New	75,000 $767,000

167

68.7M

704K

685K

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.75B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.